US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Kalvista Pharmaceuticals Inc

11.90

-0.2900-2.38%

Post-market: 11.900.00000.00%17:39 EDT

Volume:377.25K

Turnover:4.58M

Market Cap:591.62M

PE:-3.20

High:12.71

Open:12.20

Low:11.88

Close:12.19

Loading ...

Overview Company News Filings

KalVista Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

KalVista Pharmaceuticals to Present at the Citizens Life Sciences Conference

KalVista Pharmaceuticals Price Target Maintained With a $28.00/Share by Needham

KalVista Signs Deal With Kaken to Commercialize Hereditary Angioedema Treatment in Japan

MT Newswires Live

BRIEF-Kalvista Pharmaceuticals Enters Into Licensing Agreement With Kaken Pharmaceutical To Commercialize Sebetralstat For HAE In Japan

Kalvista Pharmaceuticals Inc - up to $24 Mln in Upfront and Milestone Payments, Plus Royalties

THOMSON REUTERS

Kalvista Pharmaceuticals Enters Into Licensing Agreement With Kaken Pharmaceutical to Commercialize Sebetralstat for Hae in Japan

THOMSON REUTERS

KalVista Pharmaceuticals Price Target Maintained With a $19.00/Share by Citizens Capital Markets

KalVista Pharmaceuticals Is Maintained at Buy by Jones Trading

KalVista completes enrollment in KONFIDENT-KID clinical trial of sebetralstat

KalVista Pharmaceuticals Completes Participant Enrollment Ahead of Schedule for Pediatric Hereditary Angioedema Trial

MT Newswires Live

Kalvista Pharmaceuticals Announces Early Completion of Enrollment in Konfident-Kid Pediatric Hae Trial

THOMSON REUTERS

KalVista Pharmaceuticals Announces Early Completion of Enrollment in KONFIDENT-KID Pediatric HAE Trial

KalVista Pharmaceuticals Price Target Maintained With a $20.00/Share by HC Wainwright & Co.

KalVista Pharmaceuticals Price Target Maintained With a $28.00/Share by Needham

Calendar of U.S. Earnings Expected in the Week Ahead

KalVista Pharmaceuticals to Host Investor Webcast Highlighting Commercialization Strategy, Plans and Progress for Sebetralstat in Hereditary Angioedema

Kalvista Pharmaceuticals Inc expected to post a loss of 87 cents a share - Earnings Preview

Calendar of U.S. Earnings Expected in the Week Ahead

KalVista Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/KALV/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"KALV","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"KALV\",,,,,undefined,":{"symbol":"KALV","market":"US","secType":"STK","nameCN":"Kalvista Pharmaceuticals Inc","latestPrice":11.9,"timestamp":1746820800000,"preClose":12.19,"halted":0,"volume":377248,"hourTrading":{"tag":"盘后","latestPrice":11.9,"preClose":11.9,"latestTime":"17:39 EDT","volume":6966,"amount":82897.17,"timestamp":1746826789886},"delay":0,"floatShares":29072008,"shares":49715636,"eps":-3.721859,"marketStatus":"Market Closed","change":-0.29,"latestTime":"05-09 16:00:00 EDT","open":12.2,"high":12.71,"low":11.881,"amount":4580148.351104,"amplitude":0.068007,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-3.721859,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1747036800000},"marketStatusCode":7,"adr":0,"adrRate":0,"listingDate":1479790800000,"exchange":"NASDAQ","adjPreClose":12.19,"preHourTrading":{"tag":"盘前","latestPrice":12.81,"preClose":12.19,"latestTime":"09:17 EDT","volume":4127,"amount":50353.902557,"timestamp":1746796672225},"postHourTrading":{"tag":"盘后","latestPrice":11.9,"preClose":11.9,"latestTime":"17:39 EDT","volume":6966,"amount":82897.17,"timestamp":1746826789886},"volumeRatio":0.6619208140587596,"impliedVol":1.0881,"impliedVolPercentile":0.808},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"KALV\",,,,,undefined,":{"symbol":"KALV","floatShares":29072008,"roa":"-58.15%","roe":"-150.50%","lyrEps":-3.442668,"volumeRatio":0.6619208140587596,"shares":49715636,"dividePrice":0,"high":12.71,"amplitude":0.068007,"preClose":12.19,"low":11.881,"week52Low":7.3,"pbRate":"4.08","week52High":15.5,"institutionHeld":0,"latestPrice":11.9,"eps":-3.721859,"divideRate":0,"volume":377248,"delay":0,"ttmEps":-3.721859,"open":12.2,"prevYearClose":8.47,"prevWeekClose":13.55,"prevMonthClose":13.77,"prevQuarterClose":11.54,"fiveDayClose":13.55,"twentyDayClose":10.54,"sixtyDayClose":9.33},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"KALV\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2532812327","title":"KalVista Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)","url":"https://stock-news.laohu8.com/highlight/detail?id=2532812327","media":"Business Wire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2532812327?lang=en_us&edition=fundamental","pubTime":"2025-05-02 19:00","pubTimestamp":1746183600,"startTime":"0","endTime":"0","summary":"CAMBRIDGE, Mass. & SALISBURY, England, May 02, 2025----KalVista Pharmaceuticals, Inc. , today announced that the compensation committee of KalVista’s board of directors granted three newly-hired employees inducement options to purchase an aggregate of 14,000 shares of KalVista common stock on May 1, 2025 as inducements material to each employee entering into employment with KalVista. The options have an exercise price that is equal to the closing price of KalVista common stock on the grant date.One-fourth of the options vest on the one-year anniversary of the vesting commencement date and the remainder vest in equal monthly installments over the next three years, in each case subject to the new employee’s continued service with the company. Each stock option has a 10-year term and is subject to the terms and conditions of KalVista’s Inducement Equity Incentive Plan and a stock option agreement covering the grant.The options were granted in accordance with Nasdaq Listing Rule 5635.KalVi","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/kalvista-pharmaceuticals-reports-inducement-grants-110000873.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["QLD","USAW.SI","IE00BLDYK493.USD","KALV","LU0106261612.USD","NVIW.SI","HAE","LU0205193047.USD","NQmain","LU1169590202.USD","IE00B64QTZ34.USD","LU0012050646.USD","BK4139","LU1169589451.USD","QID","MNQmain","BK4112","LU2210149790.SGD","BK4585","IE00B64PRP62.GBP","LU0205194284.USD","IE00BGHQF748.EUR","BK4588","PSQ","BK4198","IE00BKPKM429.USD","NDAQ",".IXIC","USJW.SI","SQQQ","TSYW.SI","IE00B3QW5Z07.USD","LU2210150020.SGD","LU2095319765.USD","TQQQ"],"gpt_icon":1},{"id":"2531036881","title":"KalVista Pharmaceuticals to Present at the Citizens Life Sciences Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2531036881","media":"Business Wire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531036881?lang=en_us&edition=fundamental","pubTime":"2025-04-30 19:00","pubTimestamp":1746010800,"startTime":"0","endTime":"0","summary":"CAMBRIDGE, Mass. & SALISBURY, England, April 30, 2025----KalVista Pharmaceuticals, Inc. , today announced that the Company will participate in a fireside chat at the Citizens Life Sciences Conference on Wednesday, May 7, 2025 at 11:30 a.m. ET.A live webcast of the presentation will be available on the Company’s website at www.kalvista.com. An audio archive will be available on KalVista’s website for 30 days following the presentations.KalVista Pharmaceuticals, Inc., is a global biopharmaceutical company dedicated to developing and delivering life-changing oral therapies for individuals affected by rare diseases with significant unmet needs. Our lead investigational product is sebetralstat, a novel, oral, on-demand treatment for hereditary angioedema . Sebetralstat is under regulatory review by the U.S. FDA, with a PDUFA goal date of June 17, 2025. In addition, we have completed Marketing Authorization Applications for sebetralstat to the European Medicines Agency and multiple other glo","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/kalvista-pharmaceuticals-present-citizens-life-110000045.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4139","HAE","IE00BLDYK493.USD","LU1169589451.USD","LU1169590202.USD","LU0205193047.USD","LU0205194284.USD","KALV","IE00B64QTZ34.USD","BK4198","LU0106261612.USD","LU0012050646.USD"],"gpt_icon":0},{"id":"2525891978","title":"KalVista Pharmaceuticals Price Target Maintained With a $28.00/Share by Needham","url":"https://stock-news.laohu8.com/highlight/detail?id=2525891978","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2525891978?lang=en_us&edition=fundamental","pubTime":"2025-04-08 20:27","pubTimestamp":1744115220,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/KALV/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  April 08, 2025 08:27 ET (12:27 GMT)","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["KALV"],"gpt_icon":0},{"id":"2525895227","title":"KalVista Signs Deal With Kaken to Commercialize Hereditary Angioedema Treatment in Japan","url":"https://stock-news.laohu8.com/highlight/detail?id=2525895227","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2525895227?lang=en_us&edition=fundamental","pubTime":"2025-04-08 19:41","pubTimestamp":1744112505,"startTime":"0","endTime":"0","summary":"KalVista Pharmaceuticals (KALV) said Tuesday its namesake unit has licensed commercialization rights for the sebetralstat experimental treatment for hereditary angioedema in Japan to Kaken Pharmaceuti","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4139","KALV"],"gpt_icon":0},{"id":"2525862752","title":"BRIEF-Kalvista Pharmaceuticals Enters Into Licensing Agreement With Kaken Pharmaceutical To Commercialize Sebetralstat For HAE In Japan","url":"https://stock-news.laohu8.com/highlight/detail?id=2525862752","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2525862752?lang=en_us&edition=fundamental","pubTime":"2025-04-08 18:31","pubTimestamp":1744108274,"startTime":"0","endTime":"0","summary":"BRIEF-Kalvista Pharmaceuticals Enters Into Licensing Agreement With Kaken Pharmaceutical To Commercialize Sebetralstat For HAE In JapanApril 8 (Reuters) - Kalvista Pharmaceuticals Inc KALV.O:KALVISTA ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250408:nTUA3QGFRP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["KALV","BK4139"],"gpt_icon":0},{"id":"2525986248","title":"Kalvista Pharmaceuticals Inc - up to $24 Mln in Upfront and Milestone Payments, Plus Royalties","url":"https://stock-news.laohu8.com/highlight/detail?id=2525986248","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2525986248?lang=en_us&edition=fundamental","pubTime":"2025-04-08 18:30","pubTimestamp":1744108200,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250408:nTUA3QGFRP:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","KALV"],"gpt_icon":0},{"id":"2525862584","title":"Kalvista Pharmaceuticals Enters Into Licensing Agreement With Kaken Pharmaceutical to Commercialize Sebetralstat for Hae in Japan","url":"https://stock-news.laohu8.com/highlight/detail?id=2525862584","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2525862584?lang=en_us&edition=fundamental","pubTime":"2025-04-08 18:30","pubTimestamp":1744108200,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250408:nTUA3QGFRP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","KALV"],"gpt_icon":0},{"id":"2522740801","title":"KalVista Pharmaceuticals Price Target Maintained With a $19.00/Share by Citizens Capital Markets","url":"https://stock-news.laohu8.com/highlight/detail?id=2522740801","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522740801?lang=en_us&edition=fundamental","pubTime":"2025-03-26 21:35","pubTimestamp":1742996100,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/KALV/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  March 26, 2025 09:35 ET (13:35 GMT)","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["KALV"],"gpt_icon":0},{"id":"2522401805","title":"KalVista Pharmaceuticals Is Maintained at Buy by Jones Trading","url":"https://stock-news.laohu8.com/highlight/detail?id=2522401805","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522401805?lang=en_us&edition=fundamental","pubTime":"2025-03-26 21:09","pubTimestamp":1742994540,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/KALV/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  March 26, 2025 09:09 ET (13:09 GMT)","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["KALV"],"gpt_icon":0},{"id":"2522881026","title":"KalVista completes enrollment in KONFIDENT-KID clinical trial of sebetralstat","url":"https://stock-news.laohu8.com/highlight/detail?id=2522881026","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522881026?lang=en_us&edition=fundamental","pubTime":"2025-03-26 02:58","pubTimestamp":1742929089,"startTime":"0","endTime":"0","summary":"KalVista (KALV) Pharmaceuticals announced the completion of enrollment in the open-label KONFIDENT-KID clinical trial of sebetralstat, an investiga...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/kalvista-completes-enrollment-in-konfident-kid-clinical-trial-of-sebetralstat?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/kalvista-completes-enrollment-in-konfident-kid-clinical-trial-of-sebetralstat?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["KALV","BK4139"],"gpt_icon":0},{"id":"2522005335","title":"KalVista Pharmaceuticals Completes Participant Enrollment Ahead of Schedule for Pediatric Hereditary Angioedema Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2522005335","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522005335?lang=en_us&edition=fundamental","pubTime":"2025-03-25 22:45","pubTimestamp":1742913950,"startTime":"0","endTime":"0","summary":"KalVista Pharmaceuticals  said Tuesday it has finished enrolling participants in the Konfident-KID clinical study of experimental oral plasma kallikrein inhibitor sebetralstat for children aged two to 11 with hereditary angioedema.Strong demand led the company to enroll about 36 participants instead of the original 24, reaching the recruitment goal a year ahead of schedule, the company said.Initial findings are expected later in this year, while the company plans to submit a supplemental New Drug Application by mid-2026, it added.The trial, spanning seven countries in North America, Europe, and Asia, aims to gather safety, pharmacokinetic, and efficacy data for up to one year, according to the company.Shares of the company were down about 2% in recent trading.Price: 12.01, Change: -0.24, Percent Change: -1.96","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["KALV","BK4139"],"gpt_icon":0},{"id":"2522407080","title":"Kalvista Pharmaceuticals Announces Early Completion of Enrollment in Konfident-Kid Pediatric Hae Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2522407080","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522407080?lang=en_us&edition=fundamental","pubTime":"2025-03-25 19:00","pubTimestamp":1742900400,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250325:nTUA9L7YKH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["KALV","BK4139"],"gpt_icon":0},{"id":"2522026810","title":"KalVista Pharmaceuticals Announces Early Completion of Enrollment in KONFIDENT-KID Pediatric HAE Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2522026810","media":"Business Wire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522026810?lang=en_us&edition=fundamental","pubTime":"2025-03-25 19:00","pubTimestamp":1742900400,"startTime":"0","endTime":"0","summary":"Initial target enrollment surpassed in fewer than seven months; trial expanded due to high demand. First data presentation expected before year-end; sNDA submission by mid-2026. CAMBRIDGE, Mass. & SALISBURY, England, March 25, 2025----KalVista Pharmaceuticals, Inc.  today announced the completion of enrollment in the open-label KONFIDENT-KID clinical trial of sebetralstat, an investigational, novel, oral plasma kallikrein inhibitor, in pediatric patients between the ages of two and 11 with hereditary angioedema .\"We're proud to share that we achieved target enrollment in our KONFIDENT-KID trial a full year ahead of schedule and expanded the trial size due to overwhelming interest,\" said Ben Palleiko, CEO of KalVista. \"The high level of participation from families living with HAE underscores the significant need for an oral treatment option for this population. Even with this larger trial size, we anticipate that initial results will be shared later this year, with an sNDA expected to b","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/kalvista-pharmaceuticals-announces-early-completion-110000702.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4139","BK4198","ODT","LU0012050646.USD","LU0205194284.USD","HAE","IE00B64QTZ34.USD","KALV","LU0205193047.USD","LU1169590202.USD","IE00BLDYK493.USD","BK4007","LU0106261612.USD","LU1169589451.USD"],"gpt_icon":0},{"id":"2519806717","title":"KalVista Pharmaceuticals Price Target Maintained With a $20.00/Share by HC Wainwright & Co.","url":"https://stock-news.laohu8.com/highlight/detail?id=2519806717","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2519806717?lang=en_us&edition=fundamental","pubTime":"2025-03-14 20:41","pubTimestamp":1741956060,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/KALV/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  March 14, 2025 08:41 ET (12:41 GMT)","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["KALV"],"gpt_icon":0},{"id":"2519881357","title":"KalVista Pharmaceuticals Price Target Maintained With a $28.00/Share by Needham","url":"https://stock-news.laohu8.com/highlight/detail?id=2519881357","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2519881357?lang=en_us&edition=fundamental","pubTime":"2025-03-13 18:17","pubTimestamp":1741861020,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/KALV/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  March 13, 2025 06:17 ET (10:17 GMT)","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["KALV"],"gpt_icon":0},{"id":"2518471593","title":"Calendar of U.S. Earnings Expected in the Week Ahead","url":"https://stock-news.laohu8.com/highlight/detail?id=2518471593","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518471593?lang=en_us&edition=fundamental","pubTime":"2025-03-11 18:00","pubTimestamp":1741687200,"startTime":"0","endTime":"0","summary":"Major companies tentatively scheduled to report quarterly earnings in the week ahead, with earnings estimates provided by FactSet Research Systems Inc.·Allbirds Inc. Class A                           4Q       4:05 PM. ·Dick's Sporting Gds                              4Q      3.52   7:00 AM. ·E. W. Scripps Co                                 4Q      1.01       AMC. ·European Wax Ctr                                4Q       .06   6:00 AM. ·First Watch Rest                                4Q       .01   7:00 AM. ·Kanzhun Ltd. Sp ADR                               4Q       .22       BMO","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["EXK","LEGN","APYX","TH","NOA","SID","KSS","EWCZ","HLLY","KALV","AKBA","KFY","ASRT","VTS","PHLT","SMSI","BW","AGEN","EBR","ATLC","BIRD","SKYX","SPRB","BTMD","WEST","BZ","DKS","AFCG","BBCP","KRMD","S","ABM","SKIN","UNFI","BLDE","RMBL","WSM","LRMR","MGTX","BWAY","ARCO","FTCI","DRUG","ONDS","ACHV","SSP","ZYXI","MNTK","QRHC"],"gpt_icon":1},{"id":"2518424042","title":"KalVista Pharmaceuticals to Host Investor Webcast Highlighting Commercialization Strategy, Plans and Progress for Sebetralstat in Hereditary Angioedema","url":"https://stock-news.laohu8.com/highlight/detail?id=2518424042","media":"Business Wire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518424042?lang=en_us&edition=fundamental","pubTime":"2025-03-10 19:00","pubTimestamp":1741604400,"startTime":"0","endTime":"0","summary":"Webcast scheduled for Tuesday, March 25 at 8:00 am ET. CAMBRIDGE, Mass. & SALISBURY, England, March 10, 2025----KalVista Pharmaceuticals, Inc.  today announced that it will host a virtual event to provide an overview of the commercialization strategy, plans and progress for sebetralstat, the Company’s investigational treatment for hereditary angioedema . The event will take place on Tuesday, March 25, 2025, from 8:00 a.m. to 10:00 a.m. ET. To register, please click here.In addition to presentations by KalVista’s management team, leading external experts in HAE will discuss the current treatment guidelines and unmet needs for people living with HAE, and how sebetralstat could provide a new treatment option. A live question-and-answer session will follow the formal presentations.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/kalvista-pharmaceuticals-host-investor-webcast-110000775.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU0012050646.USD","BK4595","LU2065732104.USD","IE00B64QTZ34.USD","PRGS","HAE","BK4585","BK4139","LU0106261612.USD","LU1169589451.USD","BK4588","HST","BK4198","BK4516","BK4181","BK4023","STRK","IE00BLDYK493.USD","BK4596","LU0205193047.USD","BK4218","KALV","BK4097","LU1169590202.USD","LU0205194284.USD","BK4600"],"gpt_icon":1},{"id":"2517090480","title":"Kalvista Pharmaceuticals Inc  expected to post a loss of 87 cents a share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2517090480","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517090480?lang=en_us&edition=fundamental","pubTime":"2025-03-07 21:21","pubTimestamp":1741353668,"startTime":"0","endTime":"0","summary":"Kalvista Pharmaceuticals Inc  expected to post a loss of87cents a share - Earnings Preview Kalvista Pharmaceuticals Inc KALV.OQ KALV.O is expected to show no change in quarterly revenue when it report","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250307:nL5N3PQ15U:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["KALV"],"gpt_icon":0},{"id":"2517859394","title":"Calendar of U.S. Earnings Expected in the Week Ahead","url":"https://stock-news.laohu8.com/highlight/detail?id=2517859394","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517859394?lang=en_us&edition=fundamental","pubTime":"2025-03-07 19:00","pubTimestamp":1741345200,"startTime":"0","endTime":"0","summary":"Major companies tentatively scheduled to report quarterly earnings in the week ahead, with earnings estimates provided by FactSet Research Systems Inc.·Algonquin Pwr & Utl                              4Q       .09       BMO. ·Asana Inc. Class A                              4Q      (.01)  4:05 PM. ·Auna S.A. Class A                               4Q       .15       AMC. ·Vail Resorts Inc.                                2Q      6.29   4:05 PM","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LE","BDTX","CINT","URGN","MOMO","AURA","AUNA","KRMD","BW","DKS","LRMR","FERG","KALV","CHRS","VTS","BTMD","ACET","BNTX","CIEN","DRRX","DRUG","BWMN","AEO","TBRG","ZVRA","ASRT","EVEX","HLLY","NKTR","MYPS","ORCL","EWCZ","CVGW","BBCP","WEST","FTCI","ADBE","GECC","NOA","SFIX","CDTX","CING","LMB","MGTX","SSP","ATLC","AMRN","ARCO","LEN.B"],"gpt_icon":1},{"id":"2516204946","title":"KalVista Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)","url":"https://stock-news.laohu8.com/highlight/detail?id=2516204946","media":"Business Wire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516204946?lang=en_us&edition=fundamental","pubTime":"2025-03-04 20:00","pubTimestamp":1741089600,"startTime":"0","endTime":"0","summary":"CAMBRIDGE, Mass. & SALISBURY, England, March 04, 2025----KalVista Pharmaceuticals, Inc. , today announced that the compensation committee of KalVista’s board of directors granted two newly-hired employees inducement options to purchase an aggregate of 14,000 shares of KalVista common stock on March 3, 2025 as inducements material to each employee entering into employment with KalVista. The options have an exercise price that is equal to the closing price of KalVista common stock on the grant date.One-fourth of the options vest on the one-year anniversary of the vesting commencement date and the remainder vest in equal monthly installments over the next three years, in each case subject to the new employee’s continued service with the company. Each stock option has a 10-year term and is subject to the terms and conditions of KalVista’s Inducement Equity Incentive Plan and a stock option agreement covering the grant.The options were granted in accordance with Nasdaq Listing Rule 5635.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/kalvista-pharmaceuticals-reports-inducement-grants-120000679.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU1169589451.USD","LU0205193047.USD","IE00B64PRP62.GBP","LU1169590202.USD","BK4585",".IXIC","IE00B3QW5Z07.USD","KALV","LU2095319765.USD","HAE","LU2210150020.SGD","IE00B64QTZ34.USD","BK4588","LU0106261612.USD","NDAQ","IE00BKPKM429.USD","BK4139","BK4198","IE00BLDYK493.USD","BK4112","LU0205194284.USD","IE00BGHQF748.EUR","LU2210149790.SGD","LU0012050646.USD"],"gpt_icon":0}],"pageSize":20,"totalPage":4,"pageCount":1,"totalSize":75,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/KALV\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-03-12","symbol":"KALV","fiscalQuarterEnding":"2025/01","expectedEps":-0.89,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1741752000000,"reportTimeType":"pre","actualEps":-0.92},{"market":"US","date":"2024-12-05","symbol":"KALV","fiscalQuarterEnding":"2024/10","expectedEps":-0.92,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1733374800000,"reportTimeType":"pre","actualEps":-0.91},{"market":"US","date":"2024-09-05","symbol":"KALV","fiscalQuarterEnding":"2024/07","expectedEps":-0.95,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1725508800000,"reportTimeType":"pre","actualEps":-0.87},{"market":"US","date":"2024-07-11","symbol":"KALV","fiscalQuarterEnding":"2024/04","expectedEps":-0.71,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1720670400000,"reportTimeType":"pre","actualEps":-1.02},{"market":"US","date":"2024-03-11","symbol":"KALV","fiscalQuarterEnding":"2024/01","expectedEps":-0.75,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1710129600000,"reportTimeType":"pre","actualEps":-0.84}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"KALV\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"KALV\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.4,"buy":0.6,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.6,"analysts":10,"updateTime":1738382400000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/KALV\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"KALV","date":"2025-05-09","current":-3.445977,"percent":0.716721,"low":-26.712933,"twenty":-8.258628,"median":-4.403684,"eighty":-3.093551,"high":-1.157457,"avg":-6.04553,"sd":4.387055,"marketCap":606033602},"quantilePoints":[{"date":"2020-05-15","current":-5.832083,"twenty":-23.201672,"median":-10.386055,"eighty":-5.2222,"marketCap":181132829},{"date":"2020-05-22","current":-6.515844,"twenty":-23.104796,"median":-10.355854,"eighty":-5.22822,"marketCap":202369092},{"date":"2020-05-29","current":-6.464131,"twenty":-23.095109,"median":-10.327163,"eighty":-5.232184,"marketCap":200762988},{"date":"2020-06-05","current":-6.728442,"twenty":-23.066153,"median":-10.244593,"eighty":-5.254029,"marketCap":208971964},{"date":"2020-06-12","current":-5.981476,"twenty":-22.950428,"median":-10.155044,"eighty":-5.260852,"marketCap":185772685},{"date":"2020-06-19","current":-6.280263,"twenty":-22.894092,"median":-10.094224,"eighty":-5.279109,"marketCap":195052397},{"date":"2020-06-26","current":-7.153639,"twenty":-22.886826,"median":-10.013512,"eighty":-5.288036,"marketCap":222177707},{"date":"2020-07-02","current":-7.950216,"twenty":-22.860032,"median":-9.935195,"eighty":-5.302542,"marketCap":231478495},{"date":"2020-07-10","current":-7.545656,"twenty":-22.810838,"median":-9.903412,"eighty":-5.312067,"marketCap":219699327},{"date":"2020-07-17","current":-7.527267,"twenty":-22.730561,"median":-9.877142,"eighty":-5.315215,"marketCap":219163910},{"date":"2020-07-24","current":-7.184004,"twenty":-22.664319,"median":-9.844327,"eighty":-5.326193,"marketCap":209169465},{"date":"2020-07-31","current":-6.025492,"twenty":-22.638138,"median":-9.810399,"eighty":-5.336535,"marketCap":175438211},{"date":"2020-08-07","current":-7.110448,"twenty":-22.588934,"median":-9.79503,"eighty":-5.341955,"marketCap":207027798},{"date":"2020-08-14","current":-7.784714,"twenty":-22.494481,"median":-9.789599,"eighty":-5.34884,"marketCap":226659744},{"date":"2020-08-21","current":-8.152496,"twenty":-22.414559,"median":-9.777309,"eighty":-5.352279,"marketCap":237368079},{"date":"2020-08-28","current":-8.282455,"twenty":-22.346746,"median":-9.731861,"eighty":-5.358125,"marketCap":241151968},{"date":"2020-09-04","current":-8.024205,"twenty":-22.146371,"median":-9.678449,"eighty":-5.362022,"marketCap":233632753},{"date":"2020-09-11","current":-8.368539,"twenty":-22.010745,"median":-9.673761,"eighty":-5.364004,"marketCap":243658373},{"date":"2020-09-18","current":-7.576867,"twenty":-21.964088,"median":-9.61126,"eighty":-5.367091,"marketCap":246945238},{"date":"2020-09-25","current":-7.082365,"twenty":-21.859947,"median":-9.602702,"eighty":-5.36913,"marketCap":230828435},{"date":"2020-10-02","current":-7.126321,"twenty":-21.733762,"median":-9.556724,"eighty":-5.375898,"marketCap":232261040},{"date":"2020-10-09","current":-7.423022,"twenty":-21.650085,"median":-9.547512,"eighty":-5.382707,"marketCap":241931122},{"date":"2020-10-16","current":-8.906527,"twenty":-21.519526,"median":-9.508557,"eighty":-5.383999,"marketCap":290281531},{"date":"2020-10-23","current":-8.373564,"twenty":-21.494319,"median":-9.491795,"eighty":-5.391067,"marketCap":272911199},{"date":"2020-10-30","current":-9.455974,"twenty":-21.467137,"median":-9.474323,"eighty":-5.405759,"marketCap":308189090},{"date":"2020-11-06","current":-9.351579,"twenty":-21.421146,"median":-9.458721,"eighty":-5.413752,"marketCap":304786654},{"date":"2020-11-13","current":-10.329593,"twenty":-21.379838,"median":-9.482882,"eighty":-5.420362,"marketCap":336662109},{"date":"2020-11-20","current":-10.296627,"twenty":-21.364718,"median":-9.503773,"eighty":-5.4414,"marketCap":335587655},{"date":"2020-11-27","current":-10.697723,"twenty":-21.351758,"median":-9.524282,"eighty":-5.469478,"marketCap":348660173},{"date":"2020-12-04","current":-10.576844,"twenty":-21.343926,"median":-9.55135,"eighty":-5.491169,"marketCap":344720510},{"date":"2020-12-11","current":-9.10257,"twenty":-21.305311,"median":-9.55135,"eighty":-5.504745,"marketCap":337850985},{"date":"2020-12-18","current":-8.556319,"twenty":-21.267517,"median":-9.540006,"eighty":-5.542408,"marketCap":317576338},{"date":"2020-12-24","current":-8.469306,"twenty":-21.232957,"median":-9.507547,"eighty":-5.550337,"marketCap":314346748},{"date":"2020-12-31","current":-9.179915,"twenty":-21.044795,"median":-9.483591,"eighty":-5.562231,"marketCap":340721732},{"date":"2021-01-08","current":-8.043907,"twenty":-20.978555,"median":-9.467896,"eighty":-5.567258,"marketCap":298557642},{"date":"2021-01-15","current":-8.406463,"twenty":-20.947835,"median":-9.448647,"eighty":-5.576974,"marketCap":312014266},{"date":"2021-01-22","current":-7.797369,"twenty":-20.938867,"median":-9.422699,"eighty":-5.602707,"marketCap":289407137},{"date":"2021-01-29","current":-7.347799,"twenty":-20.726504,"median":-9.405114,"eighty":-5.628372,"marketCap":272720923},{"date":"2021-02-05","current":-7.352633,"twenty":-20.546505,"median":-9.373611,"eighty":-5.646403,"marketCap":272900344},{"date":"2021-02-12","current":-26.712933,"twenty":-20.726504,"median":-9.392928,"eighty":-5.654228,"marketCap":991477223},{"date":"2021-02-19","current":-24.554312,"twenty":-20.988155,"median":-9.414413,"eighty":-5.67951,"marketCap":911357851},{"date":"2021-02-26","current":-20.626124,"twenty":-21.258877,"median":-9.440089,"eighty":-5.72406,"marketCap":765559228},{"date":"2021-03-05","current":-19.377387,"twenty":-21.138876,"median":-9.458721,"eighty":-5.739303,"marketCap":719211103},{"date":"2021-03-12","current":-20.860166,"twenty":-20.989664,"median":-9.482882,"eighty":-5.748647,"marketCap":790016207},{"date":"2021-03-19","current":-20.783144,"twenty":-21.258877,"median":-9.503773,"eighty":-5.76543,"marketCap":787099224},{"date":"2021-03-26","current":-17.971835,"twenty":-21.214778,"median":-9.540006,"eighty":-5.797608,"marketCap":680629348},{"date":"2021-04-01","current":-17.625236,"twenty":-21.149559,"median":-9.55135,"eighty":-5.814845,"marketCap":667502924},{"date":"2021-04-09","current":-16.78441,"twenty":-20.99371,"median":-9.556921,"eighty":-5.818293,"marketCap":635659194},{"date":"2021-04-16","current":-15.693263,"twenty":-20.976773,"median":-9.61126,"eighty":-5.832083,"marketCap":594335269},{"date":"2021-04-23","current":-15.7061,"twenty":-20.967275,"median":-9.612147,"eighty":-5.83668,"marketCap":594821433},{"date":"2021-04-30","current":-16.027026,"twenty":-20.940526,"median":-9.678093,"eighty":-5.856215,"marketCap":606975529},{"date":"2021-05-07","current":-16.187489,"twenty":-20.9218,"median":-9.704874,"eighty":-5.863141,"marketCap":613052577},{"date":"2021-05-14","current":-16.726644,"twenty":-20.857283,"median":-9.745168,"eighty":-5.877022,"marketCap":633471457},{"date":"2021-05-21","current":-16.811935,"twenty":-20.83323,"median":-9.785618,"eighty":-5.896668,"marketCap":636701587},{"date":"2021-05-28","current":-17.41167,"twenty":-20.75174,"median":-9.79099,"eighty":-5.90442,"marketCap":659414763},{"date":"2021-06-04","current":-17.04409,"twenty":-20.626124,"median":-9.799069,"eighty":-5.913345,"marketCap":645493784},{"date":"2021-06-11","current":-18.533755,"twenty":-20.586034,"median":-9.811455,"eighty":-5.918271,"marketCap":701910381},{"date":"2021-06-18","current":-18.075893,"twenty":-20.520152,"median":-9.843589,"eighty":-5.941255,"marketCap":684570215},{"date":"2021-06-25","current":-18.030752,"twenty":-20.513378,"median":-9.870785,"eighty":-5.97573,"marketCap":682860621},{"date":"2021-07-02","current":-15.115909,"twenty":-20.487751,"median":-9.886663,"eighty":-5.97573,"marketCap":572469705},{"date":"2021-07-09","current":-14.806368,"twenty":-20.470471,"median":-9.906604,"eighty":-5.980327,"marketCap":560746776},{"date":"2021-07-16","current":-11.577795,"twenty":-20.442465,"median":-9.931245,"eighty":-6.013653,"marketCap":535403539},{"date":"2021-07-23","current":-11.239603,"twenty":-20.41703,"median":-9.935195,"eighty":-6.024733,"marketCap":519764184},{"date":"2021-07-30","current":-10.642482,"twenty":-20.36895,"median":-10.02465,"eighty":-6.037857,"marketCap":492150948},{"date":"2021-08-06","current":-10.526229,"twenty":-20.35815,"median":-10.080791,"eighty":-6.080593,"marketCap":486774920},{"date":"2021-08-13","current":-10.203889,"twenty":-20.33223,"median":-10.138374,"eighty":-6.114291,"marketCap":471868660},{"date":"2021-08-20","current":-9.728714,"twenty":-20.32575,"median":-10.088058,"eighty":-6.156324,"marketCap":449894651},{"date":"2021-08-27","current":-11.134384,"twenty":-20.299987,"median":-10.138374,"eighty":-6.165345,"marketCap":514898441},{"date":"2021-09-03","current":-10.706341,"twenty":-20.267469,"median":-10.155617,"eighty":-6.18096,"marketCap":495104053},{"date":"2021-09-10","current":-9.578084,"twenty":-20.245297,"median":-10.155617,"eighty":-6.21797,"marketCap":493644893},{"date":"2021-09-17","current":-9.12763,"twenty":-20.213596,"median":-10.138374,"eighty":-6.250384,"marketCap":470428920},{"date":"2021-09-24","current":-8.795716,"twenty":-20.155294,"median":-10.088058,"eighty":-6.257279,"marketCap":453322414},{"date":"2021-10-01","current":-8.217238,"twenty":-20.10972,"median":-10.041851,"eighty":-6.264174,"marketCap":423508217},{"date":"2021-10-08","current":-8.250429,"twenty":-20.053588,"median":-10.013512,"eighty":-6.268771,"marketCap":425218868},{"date":"2021-10-15","current":-8.160338,"twenty":-20.004942,"median":-9.935195,"eighty":-6.268771,"marketCap":420575673},{"date":"2021-10-22","current":-7.965932,"twenty":-19.978678,"median":-9.928498,"eighty":-6.275666,"marketCap":410556148},{"date":"2021-10-29","current":-8.525443,"twenty":-19.922322,"median":-9.903412,"eighty":-6.280263,"marketCap":439392830},{"date":"2021-11-05","current":-8.610793,"twenty":-19.879677,"median":-9.877142,"eighty":-6.281869,"marketCap":443791646},{"date":"2021-11-12","current":-8.378453,"twenty":-19.831313,"median":-9.856541,"eighty":-6.336494,"marketCap":431817092},{"date":"2021-11-19","current":-7.875841,"twenty":-19.770206,"median":-9.839276,"eighty":-6.372197,"marketCap":405912954},{"date":"2021-11-26","current":-7.150372,"twenty":-19.735066,"median":-9.812511,"eighty":-6.376794,"marketCap":368523019},{"date":"2021-12-03","current":-5.86065,"twenty":-19.683562,"median":-9.803588,"eighty":-6.374313,"marketCap":302052023},{"date":"2021-12-10","current":-5.440776,"twenty":-19.629284,"median":-9.79099,"eighty":-6.281333,"marketCap":330587011},{"date":"2021-12-17","current":-5.315932,"twenty":-19.592093,"median":-9.785618,"eighty":-6.268771,"marketCap":323001373},{"date":"2021-12-23","current":-5.815308,"twenty":-19.526544,"median":-9.758677,"eighty":-6.25482,"marketCap":353343926},{"date":"2021-12-31","current":-5.328014,"twenty":-19.427593,"median":-9.73108,"eighty":-6.165345,"marketCap":323735467},{"date":"2022-01-07","current":-5.231361,"twenty":-19.359562,"median":-9.678449,"eighty":-6.028583,"marketCap":317862714},{"date":"2022-01-14","current":-5.050136,"twenty":-19.275966,"median":-9.669428,"eighty":-5.97573,"marketCap":306851304},{"date":"2022-01-21","current":-4.675604,"twenty":-19.226786,"median":-9.61126,"eighty":-5.917549,"marketCap":284094389},{"date":"2022-01-28","current":-4.719904,"twenty":-19.038973,"median":-9.602702,"eighty":-5.872455,"marketCap":286786067},{"date":"2022-02-04","current":-5.311905,"twenty":-18.920681,"median":-9.559118,"eighty":-5.832083,"marketCap":322756675},{"date":"2022-02-11","current":-6.064996,"twenty":-18.894886,"median":-9.554037,"eighty":-5.832083,"marketCap":368515203},{"date":"2022-02-18","current":-6.26233,"twenty":-18.813739,"median":-9.549042,"eighty":-5.832083,"marketCap":380505405},{"date":"2022-02-25","current":-6.471745,"twenty":-18.753258,"median":-9.540006,"eighty":-5.850469,"marketCap":393229702},{"date":"2022-03-04","current":-6.330792,"twenty":-18.736138,"median":-9.503773,"eighty":-5.859533,"marketCap":384665271},{"date":"2022-03-11","current":-5.161388,"twenty":-18.734061,"median":-9.482882,"eighty":-5.850469,"marketCap":377720709},{"date":"2022-03-18","current":-5.245231,"twenty":-18.656282,"median":-9.460337,"eighty":-5.814845,"marketCap":383856523},{"date":"2022-03-25","current":-5.372673,"twenty":-18.605577,"median":-9.448647,"eighty":-5.750642,"marketCap":393182961},{"date":"2022-04-01","current":-5.030593,"twenty":-18.569418,"median":-9.418556,"eighty":-5.678382,"marketCap":368148840},{"date":"2022-04-08","current":-4.758941,"twenty":-18.547457,"median":-9.395816,"eighty":-5.640723,"marketCap":348268802},{"date":"2022-04-14","current":-4.815954,"twenty":-18.537748,"median":-9.373611,"eighty":-5.601865,"marketCap":352441156},{"date":"2022-04-22","current":-4.564425,"twenty":-18.461984,"median":-9.338328,"eighty":-5.560538,"marketCap":334033714},{"date":"2022-04-29","current":-4.269296,"twenty":-18.405112,"median":-9.313117,"eighty":-5.535966,"marketCap":312435648},{"date":"2022-05-06","current":-3.809836,"twenty":-18.394768,"median":-9.281755,"eighty":-5.492046,"marketCap":278811388},{"date":"2022-05-13","current":-3.25647,"twenty":-18.327474,"median":-9.263667,"eighty":-5.467356,"marketCap":238315015},{"date":"2022-05-20","current":-3.025063,"twenty":-18.279297,"median":-9.242266,"eighty":-5.434907,"marketCap":221380169},{"date":"2022-05-27","current":-3.011648,"twenty":-18.229202,"median":-9.214148,"eighty":-5.406406,"marketCap":220398438},{"date":"2022-06-03","current":-3.018356,"twenty":-18.162264,"median":-9.191891,"eighty":-5.383999,"marketCap":220889304},{"date":"2022-06-10","current":-2.800363,"twenty":-18.10833,"median":-9.167406,"eighty":-5.36913,"marketCap":204936187},{"date":"2022-06-17","current":-3.0586,"twenty":-18.095239,"median":-9.157656,"eighty":-5.356176,"marketCap":223834494},{"date":"2022-06-24","current":-3.464402,"twenty":-18.072024,"median":-9.140421,"eighty":-5.344467,"marketCap":253531834},{"date":"2022-07-01","current":-3.320191,"twenty":-18.052442,"median":-9.131967,"eighty":-5.332091,"marketCap":242978234},{"date":"2022-07-08","current":-3.303411,"twenty":-18.03602,"median":-9.129602,"eighty":-5.315932,"marketCap":271999553},{"date":"2022-07-15","current":-3.679409,"twenty":-18.030752,"median":-9.12698,"eighty":-5.299824,"marketCap":302958851},{"date":"2022-07-22","current":-4.013629,"twenty":-17.971835,"median":-9.097738,"eighty":-5.27566,"marketCap":330478228},{"date":"2022-07-29","current":-3.685377,"twenty":-17.837971,"median":-9.072071,"eighty":-5.232449,"marketCap":303450269},{"date":"2022-08-05","current":-4.106137,"twenty":-17.837971,"median":-9.006003,"eighty":-5.206415,"marketCap":338095198},{"date":"2022-08-12","current":-4.422453,"twenty":-17.837971,"median":-8.885027,"eighty":-5.187177,"marketCap":364140323},{"date":"2022-08-19","current":-4.479151,"twenty":-17.837971,"median":-8.802132,"eighty":-5.165186,"marketCap":368808788},{"date":"2022-08-26","current":-4.855149,"twenty":-17.837971,"median":-8.802132,"eighty":-5.148547,"marketCap":399768087},{"date":"2022-09-02","current":-4.816355,"twenty":-17.837971,"median":-8.754215,"eighty":-5.136538,"marketCap":396573874},{"date":"2022-09-09","current":-4.373534,"twenty":-17.837971,"median":-8.667692,"eighty":-5.127353,"marketCap":390434105},{"date":"2022-09-16","current":-4.131019,"twenty":-17.837971,"median":-8.653467,"eighty":-5.107209,"marketCap":368784324},{"date":"2022-09-23","current":-3.654257,"twenty":-17.837971,"median":-8.653467,"eighty":-5.104328,"marketCap":326222824},{"date":"2022-09-30","current":-3.998738,"twenty":-17.837971,"median":-8.653467,"eighty":-5.102379,"marketCap":356975353},{"date":"2022-10-07","current":-1.364146,"twenty":-17.837971,"median":-8.653467,"eighty":-5.092671,"marketCap":121780013},{"date":"2022-10-14","current":-1.256668,"twenty":-17.837971,"median":-8.653467,"eighty":-5.077139,"marketCap":112185224},{"date":"2022-10-21","current":-1.207062,"twenty":-17.837971,"median":-8.639242,"eighty":-5.053179,"marketCap":107756860},{"date":"2022-10-28","current":-1.408239,"twenty":-17.837971,"median":-8.551485,"eighty":-5.032505,"marketCap":125716337},{"date":"2022-11-04","current":-1.438554,"twenty":-17.837971,"median":-8.509961,"eighty":-5.025059,"marketCap":128422560},{"date":"2022-11-11","current":-1.515717,"twenty":-17.837971,"median":-8.469306,"eighty":-5.015017,"marketCap":135311126},{"date":"2022-11-18","current":-1.402728,"twenty":-17.837971,"median":-8.406531,"eighty":-4.990348,"marketCap":125224297},{"date":"2022-11-25","current":-1.430286,"twenty":-17.837971,"median":-8.383195,"eighty":-4.979261,"marketCap":127684499},{"date":"2022-12-02","current":-1.482647,"twenty":-17.837971,"median":-8.383195,"eighty":-4.97089,"marketCap":132358883},{"date":"2022-12-09","current":-1.532606,"twenty":-17.837971,"median":-8.383195,"eighty":-4.958632,"marketCap":140815818},{"date":"2022-12-16","current":-1.508491,"twenty":-17.837971,"median":-8.383195,"eighty":-4.945952,"marketCap":138600184},{"date":"2022-12-23","current":-1.369164,"twenty":-17.837971,"median":-8.383195,"eighty":-4.937657,"marketCap":125798746},{"date":"2022-12-30","current":-2.509054,"twenty":-17.837971,"median":-8.383195,"eighty":-4.919678,"marketCap":230531865},{"date":"2023-01-06","current":-2.471938,"twenty":-17.837971,"median":-8.383195,"eighty":-4.911339,"marketCap":227121631},{"date":"2023-01-13","current":-2.635249,"twenty":-17.837971,"median":-8.383195,"eighty":-4.865413,"marketCap":242126663},{"date":"2023-01-20","current":-2.761444,"twenty":-17.837971,"median":-8.383195,"eighty":-4.846147,"marketCap":253721461},{"date":"2023-01-27","current":-3.017546,"twenty":-17.837971,"median":-8.383195,"eighty":-4.818838,"marketCap":277252081},{"date":"2023-02-03","current":-2.921043,"twenty":-17.837971,"median":-8.383195,"eighty":-4.787017,"marketCap":268385470},{"date":"2023-02-10","current":-2.954448,"twenty":-17.837971,"median":-8.383195,"eighty":-4.759049,"marketCap":271454682},{"date":"2023-02-17","current":-3.013834,"twenty":-17.837971,"median":-8.383195,"eighty":-4.738746,"marketCap":276911057},{"date":"2023-02-24","current":-2.783714,"twenty":-17.837971,"median":-8.383195,"eighty":-4.719904,"marketCap":255767602},{"date":"2023-03-03","current":-3.032392,"twenty":-17.837971,"median":-8.383195,"eighty":-4.706024,"marketCap":278616174},{"date":"2023-03-10","current":-2.621609,"twenty":-17.837971,"median":-8.383195,"eighty":-4.665707,"marketCap":237819288},{"date":"2023-03-17","current":-2.783577,"twenty":-17.837971,"median":-8.383195,"eighty":-4.630686,"marketCap":252512146},{"date":"2023-03-24","current":-2.452109,"twenty":-17.837971,"median":-8.383195,"eighty":-4.578352,"marketCap":222443041},{"date":"2023-03-31","current":-2.960611,"twenty":-17.79335,"median":-8.380824,"eighty":-4.538256,"marketCap":268571782},{"date":"2023-04-06","current":-2.911644,"twenty":-17.79335,"median":-8.380824,"eighty":-4.528094,"marketCap":264129755},{"date":"2023-04-14","current":-3.066078,"twenty":-17.837971,"median":-8.383195,"eighty":-4.486449,"marketCap":278139225},{"date":"2023-04-21","current":-3.073611,"twenty":-17.837971,"median":-8.383195,"eighty":-4.430028,"marketCap":278822614},{"date":"2023-04-28","current":-3.148945,"twenty":-17.837971,"median":-8.383195,"eighty":-4.400655,"marketCap":285656501},{"date":"2023-05-05","current":-3.518079,"twenty":-17.837971,"median":-8.383195,"eighty":-4.363613,"marketCap":319142550},{"date":"2023-05-12","current":-3.66498,"twenty":-17.837971,"median":-8.383195,"eighty":-4.321917,"marketCap":332468631},{"date":"2023-05-19","current":-3.917347,"twenty":-17.837971,"median":-8.383195,"eighty":-4.262531,"marketCap":355362155},{"date":"2023-05-26","current":-3.67628,"twenty":-17.837971,"median":-8.383195,"eighty":-4.171033,"marketCap":333493714},{"date":"2023-06-02","current":-3.796813,"twenty":-17.837971,"median":-8.383195,"eighty":-4.121066,"marketCap":344427935},{"date":"2023-06-09","current":-3.762913,"twenty":-17.837971,"median":-8.383195,"eighty":-4.074132,"marketCap":341352685},{"date":"2023-06-16","current":-3.627313,"twenty":-17.837971,"median":-8.383195,"eighty":-4.015419,"marketCap":329051687},{"date":"2023-06-23","current":-3.74408,"twenty":-17.882593,"median":-8.385161,"eighty":-3.981381,"marketCap":339644213},{"date":"2023-06-30","current":-3.390012,"twenty":-17.927214,"median":-8.387126,"eighty":-3.936556,"marketCap":307524942},{"date":"2023-07-07","current":-3.371179,"twenty":-17.927214,"median":-8.387126,"eighty":-3.918102,"marketCap":305816470},{"date":"2023-07-14","current":-3.596288,"twenty":-17.927214,"median":-8.387126,"eighty":-3.881733,"marketCap":334120355},{"date":"2023-07-21","current":-3.555756,"twenty":-17.927214,"median":-8.387126,"eighty":-3.85357,"marketCap":330354654},{"date":"2023-07-28","current":-3.518909,"twenty":-17.927214,"median":-8.387126,"eighty":-3.806286,"marketCap":326931290},{"date":"2023-08-04","current":-4.078987,"twenty":-17.927214,"median":-8.383195,"eighty":-3.787773,"marketCap":378966428},{"date":"2023-08-11","current":-3.998083,"twenty":-17.927214,"median":-8.359487,"eighty":-3.787773,"marketCap":371449889},{"date":"2023-08-18","current":-4.031277,"twenty":-17.927214,"median":-8.304947,"eighty":-3.787773,"marketCap":374533883},{"date":"2023-08-25","current":-3.911409,"twenty":-17.927214,"median":-8.276306,"eighty":-3.787773,"marketCap":363397239},{"date":"2023-09-01","current":-4.001771,"twenty":-17.927214,"median":-8.250429,"eighty":-3.787773,"marketCap":371792555},{"date":"2023-09-08","current":-3.918109,"twenty":-17.612375,"median":-8.208265,"eighty":-3.787773,"marketCap":372933484},{"date":"2023-09-15","current":-3.603649,"twenty":-17.509147,"median":-8.131888,"eighty":-3.767896,"marketCap":343002476},{"date":"2023-09-22","current":-3.455454,"twenty":-17.302041,"median":-8.043907,"eighty":-3.739154,"marketCap":328897058},{"date":"2023-09-29","current":-3.491599,"twenty":-17.040221,"median":-8.003865,"eighty":-3.711696,"marketCap":332337404},{"date":"2023-10-06","current":-3.545817,"twenty":-16.78441,"median":-7.931827,"eighty":-3.68029,"marketCap":337497922},{"date":"2023-10-13","current":-3.318104,"twenty":-16.726644,"median":-7.865046,"eighty":-3.665109,"marketCap":315823744},{"date":"2023-10-20","current":-3.198825,"twenty":-16.484024,"median":-7.827443,"eighty":-3.643446,"marketCap":304470603},{"date":"2023-10-27","current":-2.909666,"twenty":-16.240274,"median":-7.800236,"eighty":-3.634846,"marketCap":276947836},{"date":"2023-11-03","current":-3.131957,"twenty":-16.139992,"median":-7.76349,"eighty":-3.619654,"marketCap":298105963},{"date":"2023-11-10","current":-2.833762,"twenty":-16.012905,"median":-7.693722,"eighty":-3.600705,"marketCap":269723110},{"date":"2023-11-17","current":-2.750628,"twenty":-15.893521,"median":-7.611776,"eighty":-3.579671,"marketCap":261810315},{"date":"2023-11-24","current":-2.945811,"twenty":-15.740872,"median":-7.585145,"eighty":-3.551016,"marketCap":280388182},{"date":"2023-12-01","current":-3.050631,"twenty":-15.367493,"median":-7.560499,"eighty":-3.53878,"marketCap":290365185},{"date":"2023-12-08","current":-3.082194,"twenty":-14.897334,"median":-7.527267,"eighty":-3.509271,"marketCap":309991619},{"date":"2023-12-15","current":-3.607919,"twenty":-14.808948,"median":-7.401044,"eighty":-3.490153,"marketCap":362866444},{"date":"2023-12-22","current":-3.8725,"twenty":-14.50411,"median":-7.357088,"eighty":-3.490153,"marketCap":389476650},{"date":"2023-12-29","current":-4.150825,"twenty":-14.108779,"median":-7.326046,"eighty":-3.488707,"marketCap":417469204},{"date":"2024-01-05","current":-4.030561,"twenty":-13.968443,"median":-7.294625,"eighty":-3.487262,"marketCap":405373656},{"date":"2024-01-12","current":-4.508181,"twenty":-13.685978,"median":-7.184004,"eighty":-3.487262,"marketCap":453410262},{"date":"2024-01-19","current":-4.281397,"twenty":-13.439469,"median":-7.118384,"eighty":-3.485816,"marketCap":430601514},{"date":"2024-01-26","current":-4.415406,"twenty":-13.314139,"median":-7.07687,"eighty":-3.487262,"marketCap":444079410},{"date":"2024-02-02","current":-5.408442,"twenty":-13.179889,"median":-7.005442,"eighty":-3.487262,"marketCap":543954079},{"date":"2024-02-09","current":-5.119809,"twenty":-12.983332,"median":-6.875358,"eighty":-3.487262,"marketCap":514924764},{"date":"2024-02-16","current":-5.071703,"twenty":-12.906354,"median":-6.785901,"eighty":-3.487262,"marketCap":510086544},{"date":"2024-02-23","current":-5.200236,"twenty":-12.550065,"median":-6.722697,"eighty":-3.487262,"marketCap":523013764},{"date":"2024-03-01","current":-5.642546,"twenty":-12.446128,"median":-6.628065,"eighty":-3.488707,"marketCap":567499036},{"date":"2024-03-08","current":-5.789293,"twenty":-12.214813,"median":-6.524463,"eighty":-3.488707,"marketCap":582258169},{"date":"2024-03-15","current":-4.84211,"twenty":-11.98198,"median":-6.473684,"eighty":-3.488707,"marketCap":524400519},{"date":"2024-03-22","current":-4.733036,"twenty":-11.754396,"median":-6.452984,"eighty":-3.488707,"marketCap":512587796},{"date":"2024-03-28","current":-4.312322,"twenty":-11.689964,"median":-6.424518,"eighty":-3.488707,"marketCap":467024436},{"date":"2024-04-05","current":-4.366859,"twenty":-11.578128,"median":-6.377487,"eighty":-3.487262,"marketCap":472930798},{"date":"2024-04-12","current":-4.713558,"twenty":-11.456327,"median":-6.282939,"eighty":-3.487262,"marketCap":510478381},{"date":"2024-04-19","current":-4.479828,"twenty":-11.332917,"median":-6.268771,"eighty":-3.487262,"marketCap":485165404},{"date":"2024-04-26","current":-4.086383,"twenty":-11.226921,"median":-6.257279,"eighty":-3.488707,"marketCap":442555225},{"date":"2024-05-03","current":-4.740827,"twenty":-11.166695,"median":-6.165345,"eighty":-3.488707,"marketCap":513431562},{"date":"2024-05-10","current":-4.709663,"twenty":-11.03278,"median":-6.075064,"eighty":-3.488707,"marketCap":510056498},{"date":"2024-05-17","current":-4.701872,"twenty":-10.939114,"median":-5.978603,"eighty":-3.488707,"marketCap":509212732},{"date":"2024-05-24","current":-4.398023,"twenty":-10.832897,"median":-5.927156,"eighty":-3.488707,"marketCap":476305861},{"date":"2024-05-31","current":-4.382441,"twenty":-10.777169,"median":-5.860731,"eighty":-3.488707,"marketCap":474618330},{"date":"2024-06-07","current":-4.616171,"twenty":-10.70117,"median":-5.823695,"eighty":-3.488707,"marketCap":499931307},{"date":"2024-06-14","current":-4.775887,"twenty":-10.639666,"median":-5.789293,"eighty":-3.487262,"marketCap":517228508},{"date":"2024-06-21","current":-4.366859,"twenty":-10.592045,"median":-5.743022,"eighty":-3.485816,"marketCap":472930798},{"date":"2024-06-28","current":-4.694081,"twenty":-10.565199,"median":-5.678382,"eighty":-3.482924,"marketCap":508368966},{"date":"2024-07-05","current":-4.565529,"twenty":-10.495844,"median":-5.642546,"eighty":-3.482924,"marketCap":494446829},{"date":"2024-07-12","current":-4.218088,"twenty":-10.414455,"median":-5.553539,"eighty":-3.482924,"marketCap":534195587},{"date":"2024-07-15","current":-4.40031,"twenty":-10.409422,"median":-5.54036,"eighty":-3.482924,"marketCap":557272836},{"date":"2024-08-02","current":-4.666893,"twenty":-10.251448,"median":-5.48052,"eighty":-3.474463,"marketCap":591033998},{"date":"2024-08-09","current":-4.403684,"twenty":-10.203889,"median":-5.44467,"eighty":-3.474463,"marketCap":557700193},{"date":"2024-08-16","current":-4.315948,"twenty":-10.150449,"median":-5.399415,"eighty":-3.474463,"marketCap":546588925},{"date":"2024-08-23","current":-4.191093,"twenty":-10.056305,"median":-5.343903,"eighty":-3.474463,"marketCap":530776735},{"date":"2024-08-30","current":-4.422357,"twenty":-9.935195,"median":-5.305865,"eighty":-3.474463,"marketCap":560064986},{"date":"2024-09-06","current":-3.923137,"twenty":-9.927926,"median":-5.238296,"eighty":-3.474463,"marketCap":556183124},{"date":"2024-09-13","current":-3.188501,"twenty":-9.839276,"median":-5.185594,"eighty":-3.457812,"marketCap":452033837},{"date":"2024-09-20","current":-3.353108,"twenty":-9.79099,"median":-5.111459,"eighty":-3.44153,"marketCap":475370192},{"date":"2024-09-27","current":-3.04828,"twenty":-9.678669,"median":-5.089646,"eighty":-3.405079,"marketCap":432154720},{"date":"2024-10-04","current":-3.517716,"twenty":-9.578084,"median":-5.050426,"eighty":-3.405079,"marketCap":498706546},{"date":"2024-10-11","current":-3.35006,"twenty":-9.578084,"median":-5.019718,"eighty":-3.405079,"marketCap":474938037},{"date":"2024-10-18","current":-3.685371,"twenty":-9.559118,"median":-4.966028,"eighty":-3.405079,"marketCap":522475056},{"date":"2024-10-25","current":-3.679275,"twenty":-9.549042,"median":-4.935011,"eighty":-3.405079,"marketCap":521610747},{"date":"2024-10-31","current":-3.414074,"twenty":-9.499999,"median":-4.916323,"eighty":-3.405079,"marketCap":484013286},{"date":"2024-11-08","current":-3.407978,"twenty":-9.459658,"median":-4.865483,"eighty":-3.400926,"marketCap":483148976},{"date":"2024-11-15","current":-2.987315,"twenty":-9.355985,"median":-4.84211,"eighty":-3.388118,"marketCap":423511625},{"date":"2024-11-22","current":-2.842522,"twenty":-9.266243,"median":-4.810946,"eighty":-3.353539,"marketCap":402984276},{"date":"2024-11-29","current":-3.49233,"twenty":-9.214148,"median":-4.775887,"eighty":-3.353539,"marketCap":495107648},{"date":"2024-12-06","current":-2.861362,"twenty":-9.128419,"median":-4.752121,"eighty":-3.351888,"marketCap":447479863},{"date":"2024-12-13","current":-2.763403,"twenty":-9.024694,"median":-4.733036,"eighty":-3.319774,"marketCap":432160287},{"date":"2024-12-20","current":-2.556424,"twenty":-8.80559,"median":-4.718696,"eighty":-3.299339,"marketCap":399791506},{"date":"2024-12-27","current":-2.790263,"twenty":-8.741948,"median":-4.709663,"eighty":-3.280878,"marketCap":436360816},{"date":"2025-01-03","current":-2.799743,"twenty":-8.664771,"median":-4.701872,"eighty":-3.258184,"marketCap":437843355},{"date":"2025-01-10","current":-2.603824,"twenty":-8.571911,"median":-4.684342,"eighty":-3.246171,"marketCap":407204204},{"date":"2025-01-17","current":-2.606984,"twenty":-8.522598,"median":-4.669262,"eighty":-3.225423,"marketCap":407698384},{"date":"2025-01-24","current":-2.764983,"twenty":-8.495697,"median":-4.651402,"eighty":-3.208763,"marketCap":432407377},{"date":"2025-01-31","current":-2.771303,"twenty":-8.454103,"median":-4.63498,"eighty":-3.189396,"marketCap":433395737},{"date":"2025-02-07","current":-3.039901,"twenty":-8.398192,"median":-4.620066,"eighty":-3.166015,"marketCap":475401025},{"date":"2025-02-14","current":-3.011461,"twenty":-8.370549,"median":-4.608379,"eighty":-3.122648,"marketCap":470953406},{"date":"2025-02-21","current":-3.362219,"twenty":-8.342094,"median":-4.591181,"eighty":-3.108236,"marketCap":525807371},{"date":"2025-02-28","current":-3.378019,"twenty":-8.296897,"median":-4.564977,"eighty":-3.108236,"marketCap":528278270},{"date":"2025-03-07","current":-3.785657,"twenty":-8.268447,"median":-4.546052,"eighty":-3.106223,"marketCap":592027472},{"date":"2025-03-14","current":-3.462938,"twenty":-8.258628,"median":-4.532865,"eighty":-3.106223,"marketCap":609016541},{"date":"2025-03-21","current":-3.392266,"twenty":-8.258628,"median":-4.532865,"eighty":-3.106223,"marketCap":596587632},{"date":"2025-03-28","current":-3.48838,"twenty":-8.258628,"median":-4.532865,"eighty":-3.106223,"marketCap":613490948},{"date":"2025-04-04","current":-3.200038,"twenty":-8.258628,"median":-4.532865,"eighty":-3.106223,"marketCap":562780999},{"date":"2025-04-11","current":-2.97954,"twenty":-8.257985,"median":-4.512303,"eighty":-3.094438,"marketCap":524002803},{"date":"2025-04-17","current":-3.32018,"twenty":-8.257985,"median":-4.479489,"eighty":-3.094438,"marketCap":583910144},{"date":"2025-04-25","current":-3.641032,"twenty":-8.258628,"median":-4.453203,"eighty":-3.093551,"marketCap":640337391},{"date":"2025-05-02","current":-3.844568,"twenty":-8.258628,"median":-4.422453,"eighty":-3.093551,"marketCap":676132649},{"date":"2025-05-09","current":-3.445977,"twenty":-8.258628,"median":-4.403684,"eighty":-3.093551,"marketCap":606033602}],"updateTime":1746987269760}}}